心房功能性 vs 心室功能性二尖瓣反流的预后差异
本研究比较了94例心房功能性二尖瓣反流(FMR)与84例心室FMR患者接受二尖瓣修复或置换术后的结局。心房FMR组5年和10年生存率及免于再手术率均显著高于心室FMR组,心室FMR是中远期死亡的独立预测因子(校正HR 1.8,95%CI 1.001-3.26)。
要点
- 心房FMR与心室FMR基线心脏形态和功能差异显著,应区分两种病因。
- 心房FMR术后5年和10年生存及免于再手术率显著优于心室FMR。
- 心室FMR是中远期死亡的独立预测因子(校正HR 1.8,95%CI 1.001-3.26)。
核心结论
- 心房FMR与心室FMR在基线心脏形态和功能上存在重要差异,并影响住院及中远期结局。
- 早期区分两种FMR病因可能有助于制定更个体化的管理策略。
研究设计与样本
- 回顾性队列研究,纳入2002年1月至2019年3月接受二尖瓣修复或置换术的成人≥3+二尖瓣反流患者。
- 共94例心房FMR(平均年龄67.6岁)和84例心室FMR(平均年龄64岁)符合标准。
- 比较术后结局及中远期生存和再手术时间-事件率。
主要发现
- 心房FMR vs 心室FMR:合并心房颤动37.2% vs 14.3%,心力衰竭42.6% vs 63.1%。
- 心房FMR vs 心室FMR:LV射血分数60% vs 37%,至少中度LV扩张4.8% vs 40.6%,中/重度右心功能障碍15.2% vs 5.1%。
- 手术死亡率心房FMR 0% vs 心室FMR 1.2%。
- 心房FMR组5年和10年生存率及免于再手术率显著高于心室FMR组。
- 风险校正分析中,心室FMR仍是中远期死亡的显著预测因子(校正HR 1.8,95%CI 1.001-3.26)。
临床怎么用
- 对FMR患者应早期区分心房型与心室型,以指导个体化治疗决策。
- 心室FMR患者中远期死亡风险更高,术后需更密切随访。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atrial functional mitral regurgitation (FMR) occurs because of left atrial dilatation or atrial fibrillation in heart failure with preserved left ventricular (LV) function, contrary to ventricular FMR, which occurs because of LV dysfunction. Despite pathophysiological differences, current guidelines do not discriminate between these 2 entities. METHODS: From January 2002 to March 2019, all adult patients with ≥3+ mitral regurgitation who underwent mitral valve repair or replacement were identified. Postoperative outcomes and midterm time-to-event rates (survival and reoperation) were compared. RESULTS: Overall, 94 atrial FMR (mean age, 67.6 years) and 84 ventricular FMR (mean age, 64 years) patients met inclusion criteria. Differences in baseline cardiac morphology and function of the atrial FMR and ventricular FMR patients were as follows: concomitant atrial fibrillation (37.2% vs 14.3%), heart failure (42.6% vs 63.1%), LV ejection fraction (60% vs 37%), at least moderate LV dilation (4.8% vs 40.6%), and moderate/severe right heart dysfunction (15.2% vs 5.1%), respectively. Operative mortality was 0% in the atrial FMR versus 1.2% in the ventricular FMR cohort. Actuarial estimates of survival and freedom from reoperation at 5 and 10 years was significantly higher in the atrial FMR cohort versus the ventricular FMR cohort. Ventricular FMR also remained a significant predictor of midterm mortality in our risk-adjusted analysis (adjusted hazard ratio for ventricular FMR, 1.8; 95% confidence interval, 1.001-3.26). CONCLUSIONS: There are important differences in baseline characteristics in terms of cardiac morphology and function among atrial FMR and ventricular FMR patients, which appear to affect in-hospital and midterm outcomes. Because of these discrepancies, early discrimination between these 2 etiologies of FMR might facilitate more tailored approaches to management.
引用
- Hirji SA, Cote CL, Javadikasgari H, et al. Atrial functional versus ventricular functional mitral regurgitation: Prognostic implications. J Thorac Cardiovasc Surg. 2020. PMID: 33526277. doi:10.1016/j.jtcvs.2020.12.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。